1. Safety and efficacy of 1 year of tacrolimus ointment monotherapy in adults with atopic dermatitis: The European Tacrolimus Ointment Study Group;Reitamo;Arch Dermatol,2000
2. Briefing document from Patty Greene, Drug Use Data Analyst, Division of Epidemiology, Office of Surveillance and Epidemiology, FDA Center for Drug Evaluation and Research. BPCA drug use review: comparison of Elidel® cream and Protopic® ointment utilization trends following 2006 labeling changes. Available from: URL: http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/PediatricAdvisoryCommittee/UCM204723.pdf. 2009. Accessed April 5, 2015.
3. Chesney J. Summary Minutes of the Pediatric Advisory Committee. Available from: URL: http://www.fda.gov/ohrms/dockets/ac/05/minutes/2005-4089m1_Minutes.pdf. 2005. Accessed April 5, 2015.
4. A systematic review of tacrolimus ointment compared with corticosteroids in the treatment of atopic dermatitis;Svensson;Curr Med Res Opin,2011
5. Efficacy and tolerability of topical pimecrolimus and tacrolimus in the treatment of atopic dermatitis: meta-analysis of randomized controlled trials;Ashcroft;BMJ,2005